Sciwind Biosciences’ Ecnoglutide Accepted for Review by NMPA for Weight Management
Sciwind Biosciences Co., Ltd has received a significant boost as the National Medical Products Administration...
HK inno.N
Sciwind Biosciences’ Ecnoglutide Accepted for Review by China’s NMPA for Type 2 Diabetes
China-based Sciwind Biosciences Co., Ltd has announced that the National Medical Products Administration (NMPA) has...
China’s Sciwind Biosciences Partners with HK inno.N for Ecnoglutide Rights in South Korea
China’s Sciwind Biosciences Co., Ltd has entered into a licensing and partnership agreement with South...